Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoglycemic effect of astragaloside IV via modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/AKT pathway
Pin Gong, Xuyang Xiao, Shuang Wang, et al.
Journal of Ethnopharmacology (2021) Vol. 281, pp. 114558-114558
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Targeting PI3K/AKT signaling pathway in obesity
Martina S. Savova, Liliya V. Vasileva, Daniel Tews, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114244-114244
Open Access | Times Cited: 111
Targeted Gut Microbiome Therapy: Applications and Prospects of Probiotics, Fecal Microbiota Transplantation and Natural Products in the Management of Type 2 Diabetes
Luqi Qin, Bei Fan, Y. Zhou, et al.
Pharmacological Research (2025), pp. 107625-107625
Open Access | Times Cited: 1
Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review
Su Min, Ting Tang, Weiwei Tang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Astragaloside IV ameliorate acute alcohol-induced liver injury in mice via modulating gut microbiota and regulating NLRP3/caspase-1 signaling pathway
Shangong Wu, Fei Wen, Xiangbin Zhong, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 24
Zingiber striolatum phytochemicals ameliorated hyperglycemia symptoms by modulating gut microbial communities in mice with type 2 diabetes mellitus
Tingting Liu, Xiaodong Ge, Song Lu, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples
Boxun Zhang, Ke Liu, Haoyu Yang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 30
Updated Progress on Polysaccharides with Anti-Diabetic Effects through the Regulation of Gut Microbiota: Sources, Mechanisms, and Structure–Activity Relationships
Xiaoyu Zhang, Jia Wang, Tingting Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 456-456
Open Access | Times Cited: 5
Integrating 16S rDNA and metabolomics to uncover the therapeutic mechanism of electroacupuncture in type 2 diabetic rats
Yue Zhang, Xiang Wang, Deng Duping, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites
Xuqin Du, Lipeng Shi, Zhiwei Chen, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 22
Gut microbiome-derived hydrolases—an underrated target of natural product metabolism
Jiaxin He, Xiaofeng Liu, Junming Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Astragali radix (Huangqi): a time-honored nourishing herbal medicine
Yuyu Zhang, Zhejie Chen, Liping Chen, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Regulation of the intestinal flora: A potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus
Liying He, Fangqing Yang, Pan Tang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113091-113091
Open Access | Times Cited: 19
Antidiabetic effect of sciadonic acid on type 2 diabetic mice through activating the PI3K-AKT signaling pathway and altering intestinal flora
Lin Chen, Qihong Jiang, Hongling Lu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 18
The traditional Chinese medicine and non-small cell lung cancer: from a gut microbiome perspective
Xuelin Wang, Liming Hou, Meng Cui, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Metallothionein–Kidney Bean Polyphenol Complexes Showed Antidiabetic Activity in Type 2 Diabetic Rats by Improving Insulin Resistance and Regulating Gut Microbiota
Zhaohang Zuo, Weiqiao Pang, Wei Sun, et al.
Foods (2023) Vol. 12, Iss. 16, pp. 3139-3139
Open Access | Times Cited: 11
Revealing the mechanism of quinoa on type 2 diabetes based on intestinal flora and taste pathways
Chun‐Yan Zheng, Tian An, Zheng‐Ting Liang, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 12, pp. 7930-7945
Open Access | Times Cited: 11
A neutral polysaccharide from Persicaria hydropiper (L.) Spach ameliorates lipopolysaccharide-induced intestinal barrier injury via regulating the gut microbiota and modulating AKT/PI3K/mTOR and MAPK signaling pathways
Xuanxuan Cheng, Yuehua Zhu, Jiahuan Huang, et al.
Journal of Ethnopharmacology (2023) Vol. 320, pp. 117403-117403
Closed Access | Times Cited: 10
Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation
Wenjuan Ma, Jianglan Long, Linjie Dong, et al.
Journal of Ethnopharmacology (2024) Vol. 323, pp. 117752-117752
Open Access | Times Cited: 3
Evidence of traditional Chinese medicine for treating type 2 diabetes mellitus: from molecular mechanisms to clinical efficacy
Yadong Ni, Xianglong Wu, Wenhui Yao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 592-606
Open Access | Times Cited: 3
Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating MIR-21/PTEN/PI3K/AKT Signaling
Xuxi Guo, Taoqing Yin, Dongni Chen, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 23, Iss. 12, pp. 1538-1547
Closed Access | Times Cited: 9
Grafting resveratrol onto mesoporous silica nanoparticles towards efficient sustainable immunoregulation and insulin resistance alleviation for diabetic periodontitis therapy
Yujie Tan, Jing Feng, Yu Xiao, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 25, pp. 4840-4855
Closed Access | Times Cited: 14
Anti-Obesity Effect of a Tea Mixture Nano-Formulation on Rats Occurs via the Upregulation of AMP-Activated Protein Kinase/Sirtuin-1/Glucose Transporter Type 4 and Peroxisome Proliferator-Activated Receptor Gamma Pathways
Mohamed A. Salem, Nora M. Aborehab, Mai M. Abdelhafez, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 871-871
Open Access | Times Cited: 8
Gut Microbiota Targeted Approach by Natural Products in Diabetes Management: An Overview
Priyanka Sati, Praveen Dhyani, Eshita Sharma, et al.
Current Nutrition Reports (2024) Vol. 13, Iss. 2, pp. 166-185
Closed Access | Times Cited: 2
Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
Lvzhuo Zhang, Shifeng He, Lian Liu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3564-3582
Closed Access | Times Cited: 2
Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
Lipeng Shi, Xuqin Du, Biao Zuo, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top